Skip to content
OpenCapital
Get started

GT Biopharma GTBP Q4 2025 Annual earnings

Reported March 2, 2026 · After market close

EPS-$2.22Miss by $2.00
EPS estimate-$0.22

Next report

Aug 13, 2026 (In 2 weeks)
EPS estimate-$0.08

Versus estimates

Diluted EPS

Q1 2026-$0.11Miss by $0.03
Q4 2025-$2.22Miss by $2.00
Q3 2025-$0.83Miss by $0.45Q2 2025-$0.55Beat by $0.13Q1 2025-$0.76Miss by $0.12Q4 2024-$1.66Miss by $0.11

Ask the moment GT Biopharma reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did GT Biopharma report Q4 2025 earnings?
GT Biopharma (GTBP) reported Q4 2025 earnings on March 2, 2026 after market close.
What were GT Biopharma's Q4 2025 revenue and EPS?
GT Biopharma reported eps of $-2.22 for Q4 2025.
Did GT Biopharma beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.22 by $2.00.
How did GT Biopharma's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 33.7% from $-1.66.
Where can I find GT Biopharma's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001493152-26-008442) and the 10-K periodic report (0001493152-26-008443) directly on SEC EDGAR. The filing index links above go to sec.gov.